TrendTrader_777 Profile Banner
🇺🇸Stock Analyst🔥 🔥 Profile
🇺🇸Stock Analyst🔥 🔥

@TrendTrader_777

Followers
606
Following
29
Media
503
Statuses
685

📈 US Stocks Chief CFA Strategist | Senior Trader | Risk Management Strategist | Follow me for the latest daily updates. Not Financial Advice 🇺🇸

Washington, D.C
Joined November 2013
Don't wanna be here? Send us removal request.
@TrendTrader_777
🇺🇸Stock Analyst🔥 🔥
1 hour
$FOSL Strengths: Diverse brands, global distribution, debt resilience, innovation. Recent News: Debt restructured, Q3 losses, Italy deal, insider buys. Today's Rise: 18.13% gain from positive debt sentiment.
0
0
0
@TrendTrader_777
🇺🇸Stock Analyst🔥 🔥
1 hour
$PHGE Strengths: BOLT platform, FDA Fast Track/Orphan, $40M funding, strong clinical data. Recent News: $3M private placement, BX004 trial discontinued, positive FDA feedback. Today's Rise: 61.22% surge from Pyu Pyu Capital's 19.99% stake acquisition.
0
0
0
@TrendTrader_777
🇺🇸Stock Analyst🔥 🔥
4 days
$LIF News: Q4 MAU 95.8M (+20%); Nativo buy; earnings preview. Strengths: Family safety; 91M users; location tracking. Surge: Q4 beat; 25.83%+ surge; high volume.
0
0
1
@TrendTrader_777
🇺🇸Stock Analyst🔥 🔥
4 days
$MOVE News: Corvex AI merger; NVIDIA GPU lease; insider RSU. Strengths: Secure AI cloud; women's health tech; scalable sensors. Surge: GPU deal sparked 162% rise; AI market boost.
0
0
0
@TrendTrader_777
🇺🇸Stock Analyst🔥 🔥
5 days
$GLSI Recent News: FDA GP2 approval for FLAMINGO-01; 80% reduction; lock-up extended; Fast Track. Company Strengths: GLSI-100 HER2+; Phase III pipeline; debt-free; "Outperform" $45 target. Today's Rise: +42.47% to $31.77 pre-market; FDA milestone; volume 12K+; biotech surge.
0
0
1
@TrendTrader_777
🇺🇸Stock Analyst🔥 🔥
5 days
$NITO Advantages: Reduces N2O emissions 40%, extends produce shelf life, solar projects in Europe, cancer drug platform. Recent News: Positive biotech results (Jan 15), solar payment (Jan 5), share issuance. Today's Rise: Biotech momentum, energy optimism; up 56.97% to $2.59.
0
0
0
@TrendTrader_777
🇺🇸Stock Analyst🔥 🔥
6 days
$MLEC Company: Moolec Science (MLEC): Molecular farming for proteins. Advantages: Sustainable, patented tech, growth potential. News: Stock split; GLASO expansion; approvals. Rise: Low float squeeze sparked 51.25% surge.
0
0
0
@TrendTrader_777
🇺🇸Stock Analyst🔥 🔥
6 days
$SLGB Company: Smart Logistics (SLGB): Digital logistics ecosystem. Advantages: Network growth, revenue up, low cap potential. News: Northern center; H1 revenue rise; IPO. Rise: Low float sparked 237.40% surge.
0
0
0
@TrendTrader_777
🇺🇸Stock Analyst🔥 🔥
7 days
$POLA Strengths: DC power cuts fuel 70%; EV/military/telecom apps; renewable expansion. News: EV charger orders; military contracts; Q3 results; Nasdaq fixes. Surge: Low-float squeeze; order buzz; +27.98% pre-market.
0
0
0
@TrendTrader_777
🇺🇸Stock Analyst🔥 🔥
7 days
$IVF Innovative INVOcell tech reduces IVF costs 30-50%; clinic expansions in Midwest; revenue up 116% in 2024. Acquired clinics; PRP therapy launch; 1:8 reverse split; Q1 2025 growth. Today's Surge: Low-float squeeze; momentum trading; no new catalysts; up 261.89% pre-market.
0
0
0
@TrendTrader_777
🇺🇸Stock Analyst🔥 🔥
7 days
$BTTC Company Strengths: DAT+ framework for crypto stability; $200M convertible note; 71.67% 1-yr returns; merger-enhanced ops. Recent News: $200M funding; DAT+ pillars rollout; Titan merger. Today's Surge: Funding optimism; momentum trading; up 69.41% pre-market.
0
0
0
@TrendTrader_777
🇺🇸Stock Analyst🔥 🔥
11 days
$MU Micron Strengths: Memory leader (DRAM, NAND, HBM), AI products, US expansions, strong R&D. Recent News: $7.8M insider buy, strong buy upgrades, Q1 revenue +57%, FY25 +244%. Today's Surge: +5.44% to $354.95, driven by insider buy, analyst hikes, sector rally.
0
1
1
@TrendTrader_777
🇺🇸Stock Analyst🔥 🔥
11 days
$TRUG TruGolf Strengths: Indoor golf simulators, E6 software, AI Coach, franchises, 69% margins. Recent News: AI Coach preview, stock buyback ($110K), redomestication plan, Q3 revenue $4.1M. Today's Surge: +6.54% to $0.8990, driven by previews, buyback, governance changes.
0
0
0
@TrendTrader_777
🇺🇸Stock Analyst🔥 🔥
11 days
$BIYA Recent News: Special meeting Jan 28, reverse split, Starfish acquisition for Web3, H1 revenue growth. Strengths: HR cloud platform, Web3 transition, >300M RMB 2025 revenue, blue-collar services. Today's 41.46% Surge: Market rally, low float volatility, technical rebound.
0
0
0
@TrendTrader_777
🇺🇸Stock Analyst🔥 🔥
12 days
$CJMB Recent News: Attune pact ($50-75M); GLP-1 shift; Q3 revenue $1.9M. Strengths: Integrated cold chain; Sentry tech; no debt; diversified. Today's Rise: Deal hype; low float; trading spike. $RFIL $OCUL $RILY $BNKK $CRWV $AMD $SNDK $CGTL $ANPA $OLB $OCUL $PEN $CINT $NVDA $TSM
0
0
0
@TrendTrader_777
🇺🇸Stock Analyst🔥 🔥
12 days
$CVGW Company: Calavo Growers (CVGW), avocado/tomato grower & processor. Advantages: Supply chain integration; diversified products; cash flow. Recent News: $430M acquisition by Mission; Q4 earnings; dividend. Rise Cause: Up 13.02% on buyout premium. $AMD $CRWV $AVGO $MU $TSM
0
0
0
@TrendTrader_777
🇺🇸Stock Analyst🔥 🔥
12 days
$ATPC Company: Agape ATP (ATPC), health/wellness products & energy solutions. Advantages: Diverse supplements; sustainable energy; ASEAN market focus. Recent News: Market activity statement; director resignation; fuel deals. Rise Cause: Up 72% on speculation, volume explosion.
0
0
0
@TrendTrader_777
🇺🇸Stock Analyst🔥 🔥
13 days
$BARK Recent News: Privatization bids ($1.10/share GNK, $0.90 Great Dane); Q2 revenue $107M; debt-free. Strengths: Subscription boxes; DTC/retail diversity; data customization; cash reserves. Today's Rise: New bid premium; momentum; high volume.
@TrendTrader_777
🇺🇸Stock Analyst🔥 🔥
15 days
$BARK Company Advantages: Personalized dog subscriptions, innovative products, retail diversification, debt-free status. Recent News: Q2 revenue growth; take-private proposal at $0.90/share from CEO-led group. Stock Rise: Up 21.93% on Jan 12 due to privatization bid premium.
0
0
0
@TrendTrader_777
🇺🇸Stock Analyst🔥 🔥
13 days
$IVP Recent News: Shares to 700M; convertible note; debt swap; Q3 revenue +7%; pet pharmacy plan. Strengths: Growth in revenue; online expansion; acquisitions; debt fixes; pet market boom. Today's Rise: Share increase news; momentum carryover; high volume; finance optimism.
0
0
0
@TrendTrader_777
🇺🇸Stock Analyst🔥 🔥
13 days
$GELS Target Price: $1.75 Advantages: Patented tech boosts bioavailability (22%+ for CBD), multi-use (pharma, pets, nutrition), white-label. Recent News: Preclinical CBD/antihistamine results; partnerships; $5.2M IPO. Rise Cause: 52.44% up on CBD bioavailability announcement.
0
0
0